Finance

Lists
NATCOPHARM:NSE
Natco Pharma Ltd
₹ ८००.००
+१.३४%
(+१०.६०) 1D
अक्टोबर १२, १५:३०:०१ GMT+५:३०  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for NATCOPHARM...
Open
₹ ७८९.४०
High
₹ ८०४.७५
Low
₹ ७८९.४०
Mkt. cap
१.५७ खरब
Avg. vol.
४.३६ लाख
Volume
५.०१ लाख
Dividend
०.५६%
Quarterly dividend
₹ १.१२
Ex-dividend date
२०२६ अगस्ट २०
P/E ratio
१२.६२
52-wk high
₹ १,२१६.८९
52-wk low
₹ ७८५.६५
EPS
₹ ६३.३७
Shares outstanding
१८.२३ करोड
No. of employees
४ हजार
Open
₹ ७८९.४०
High
₹ ८०४.७५
Low
₹ ७८९.४०
Mkt. cap
१.५७ खरब
Avg. vol.
४.३६ लाख
Volume
५.०१ लाख
Dividend
०.५६%
Quarterly dividend
₹ १.१२
Ex-dividend date
२०२६ अगस्ट २०
P/E ratio
१२.६२
52-wk high
₹ १,२१६.८९
52-wk low
₹ ७८५.६५
EPS
₹ ६३.३७
Shares outstanding
१८.२३ करोड
No. of employees
४ हजार
News stories
From web sources and news partners
TradingView
TradingView
·
३४ मिनेट पहिले
Stocks Are Near Records. Can Q3 Earnings Boost the Rally?
MarketBeat
MarketBeat
·
१२ मिनेट पहिले
Carlsmed (NASDAQ:CARL) Price Target Raised to $24.00
Profile
Natco Pharma is an Indian multinational pharmaceutical company based in Hyderabad. The company manufactures finished dosage formulations, active pharmaceutical ingredients and agrochemical products. It is a major producer of branded oncology medicines cardiology, diabetology and other pharma specialty drugs at affordable prices. Wikipedia
About Natco Pharma Ltd
CEORajeev Nannapaneni
Employees४.४३ हजार
Founded१९८१
HeadquartersBanjara Hills, तेलंगाना, भारत
Sector-
Last report
२०२६ अगस्ट १४
Fiscal period
Q1 2027
₹ ११.५३ / ₹ ८.८६
+३०.०६%beat
Revenue / Est. (INR)
७.३५ अरब / ७.९६ अरब
-७.६६%miss
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
१३.६३ अरब
६.४७ अरब
७.४३ अरब
७.३५ अरब
Cost of goods sold
१.७० अरब
१.३३ अरब
१.९९ अरब
१.४८ अरब
Cost of revenue
१.७० अरब
१.३३ अरब
१.९९ अरब
१.४८ अरब
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
२.०० अरब
१.५९ अरब
१.६३ अरब
१.७९ अरब
Operating expense
६.६६ अरब
४.०२ अरब
४.३८ अरब
४.४८ अरब
Total operating expenses
८.३६ अरब
५.३५ अरब
६.३७ अरब
५.९६ अरब
Operating income
५.२७ अरब
१.१२ अरब
१.०६ अरब
१.३९ अरब
Other non operating income
१.०० अरब
५८.१० करोड
-२.११ अरब
५९.२० करोड
EBT including unusual items
६.१४ अरब
१.७२ अरब
१.८० अरब
२.७० अरब
EBT excluding unusual items
६.१४ अरब
१.७२ अरब
२.०२ अरब
२.७० अरब
Income tax expense
९५.८० करोड
२०.७० करोड
-८९.२० करोड
६३.४० करोड
Effective tax rate
१५.६१%
१२.०३%
-४९.६१%
२३.४९%
Other operating expenses
४.१४ अरब
१.९६ अरब
२.२३ अरब
२.२२ अरब
Net income
५.१८ अरब
१.५२ अरब
२.६८ अरब
२.०६ अरब
Net profit margin
३८.०३%
२३.४०%
३६.०८%
२८.०९%
Earnings per share
२८.९४
८.४६
१४.९६
११.५३
Interest and investment income
-
-
२.३३ अरब
-
Interest expense
-१३.१० करोड
-९.५० करोड
-
-१३.०० करोड
Net interest expenses
-१३.१० करोड
-९.५० करोड
२.३३ अरब
-१३.०० करोड
Depreciation and amortization charges
५२.४० करोड
४६.२० करोड
५०.४० करोड
४७.१० करोड
EBITDA
५.८२ अरब
१.५७ अरब
१.५५ अरब
१.९१ अरब
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google एपहरू